GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 189 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2021. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $12,026,000 | +11.7% | 176,600 | -47.6% | 0.06% | +43.6% |
| Q2 2022 | $10,767,000 | -48.6% | 337,000 | -44.2% | 0.04% | -46.6% |
| Q1 2022 | $20,929,000 | +61.9% | 604,200 | +36.8% | 0.07% | +65.9% |
| Q4 2021 | $12,925,000 | +32.8% | 441,580 | +15.6% | 0.04% | +29.4% |
| Q3 2021 | $9,731,000 | -0.0% | 381,935 | +37.4% | 0.03% | -20.9% |
| Q2 2021 | $9,735,000 | +381.9% | 277,980 | +407.1% | 0.04% | +72.0% |
| Q1 2017 | $2,020,000 | – | 54,815 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 850,000 | $46,869,000 | 6.00% |
| Asymmetry Capital Management, L.P. | 155,232 | $8,559,000 | 5.50% |
| Grace Capital | 124,749 | $6,878,000 | 5.33% |
| Fernwood Investment Management, LLC | 187,477 | $10,337,000 | 4.88% |
| Perceptive Advisors | 5,800,996 | $319,867,000 | 4.67% |
| ArchPoint Investors | 217,510 | $11,993,000 | 3.83% |
| GREAT POINT PARTNERS LLC | 655,676 | $36,154,000 | 3.25% |
| Profit Investment Management, LLC | 42,196 | $2,328,000 | 1.44% |
| Bain Capital Public Equity Management II, LLC | 381,868 | $21,056,000 | 1.39% |
| Taylor Wealth Management Partners | 52,597 | $2,900,000 | 1.33% |